CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I clinical trial
The HEROS 2.0 trial showed that this therapeutic approach is safe and is associated with clinical benefit.
Read MoreThe HEROS 2.0 trial showed that this therapeutic approach is safe and is associated with clinical benefit.
Read MoreDr. Mohammad Hirzallah toggles between being an investigator in the Center for Space Medicine and providing neurocritical care for patients.
Read MoreThe findings open new opportunities to regulate the function of acid-producing cells in the stomach in different disease settings.
Read MoreComparing genomic sequences of gliding marsupials and non-gliding relatives revealed differences crucial to the development of gliding.
Read MoreAIM narrows the differential genetic diagnoses down to a few genes and can potentially guide the discovery of previously unknown disorders.
Read MoreSARS-CoV-2 takes advantage of powerful biological mechanisms that allow it to evolve quickly, generating variants to adapt to and persevere in human populations.
Read MoreSometimes, research inspires scientists like Dr. Ankita Thawani to dig into their artistic side to create renditions of their findings.
Read MoreA protein produced in large amounts in HSCs is key for these cells to retain their regenerative potential and avert the effects of aging.
Read MoreThis new testing method represents a paradigm shift in laboratory genetics, moving from the traditional DNA-centric approach to one focusing on the patient’s cells.
Read MoreThe researchers hope that in the future their findings could be used as a marker of effective therapeutic response.
Read More